Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aceragen Inc (ACGN)

Aceragen Inc (ACGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aceragen Inc 505 EAGLEVIEW BLVD. SUITE 212 EXTON PA 19341 USA

www.aceragen.com P: 484-348-1600

Description:

Aceragen Inc. is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. Its portfolio includes late-stage programs based on well-established biological principles. Aceragen Inc., formerly known as Idera Pharmaceuticals Inc., is based in DURHAM, N.C.

Key Statistics

Overview:

Market Capitalization, $K 3,201
Enterprise Value, $K 52,571
Shares Outstanding, K 8,424
Annual Sales, $ 4,860 K
Annual Net Income, $ -23,360 K
Last Quarter Sales, $ 2,470 K
Last Quarter Net Income, $ -21,870 K
EBIT, $ -33,180 K
60-Month Beta 1.14
% of Insider Shareholders 26.45%
% of Institutional Shareholders 22.64%
Float, K 6,195
% Float 73.55%
Short Volume Ratio 0.41

Growth:

1-Year Return -94.80%
3-Year Return -98.95%
5-Year Return -99.79%
5-Year Revenue Growth 440.00%
5-Year Earnings Growth 87.43%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.94 on 06/29/23
Next Earnings Date 07/04/24
Earnings Per Share ttm -5.66
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-17 on 01/18/23

ACGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -215.27%
Return-on-Assets % -53.04%
Profit Margin % -480.66%
Debt/Equity 0.00
Price/Sales 0.76
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 2.68
Interest Coverage -149.40
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar